Skip to main content
Fig. 1 | Trials

Fig. 1

From: Efficacy and safety of polysaccharide iron complex capsules compared with iron sucrose in hemodialysis patients: study protocol for a randomized, open-label, positive control, multicenter trial (IHOPE)

Fig. 1

Flowchart of the test scheme. Experimental group [conventional drug (erythropoietin) therapy+ iron polysaccharide complex], control group [conventional drug (erythropoietin) therapy + iron sucrose injection]. Primary outcome: TSAT 12 weeks after treatment. Secondary outcomes: iron metabolism, oxidative stress, safety evaluation, pharmacoeconomic evaluation, quality of life score, etc.

Back to article page